Last reviewed · How we verify
ESS (medical food/drug)
ESS (medical food/drug) is a Small molecule drug developed by Targeted Medical Pharma. It is currently in Phase 3 development.
ESS is a medical food/drug formulation designed to provide specialized nutritional support, likely targeting metabolic or gastrointestinal dysfunction.
At a glance
| Generic name | ESS (medical food/drug) |
|---|---|
| Sponsor | Targeted Medical Pharma |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a medical food product from Targeted Medical Pharma in Phase 3 development, ESS likely contains bioactive ingredients formulated to address specific nutritional deficiencies or support metabolic pathways relevant to its indication. The exact mechanism is not publicly detailed, but medical foods typically work through nutritional repletion, microbiome modulation, or metabolic substrate provision rather than traditional pharmacological receptor binding.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ESS (medical food/drug) CI brief — competitive landscape report
- ESS (medical food/drug) updates RSS · CI watch RSS
- Targeted Medical Pharma portfolio CI
Frequently asked questions about ESS (medical food/drug)
What is ESS (medical food/drug)?
How does ESS (medical food/drug) work?
Who makes ESS (medical food/drug)?
What development phase is ESS (medical food/drug) in?
Related
- Manufacturer: Targeted Medical Pharma — full pipeline
- Compare: ESS (medical food/drug) vs similar drugs
- Pricing: ESS (medical food/drug) cost, discount & access